Ebcay, Keziah Faye D.
HRN: 21-22-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/02/2022
AMPICILLIN 250MG (VIAL)
11/02/2022
11/09/2022
IV
120mg
Q6hours
URTI
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes